GovChime
Notice ID: 7da647f0e08a7d4f719d2ab8fc59c245Special Notice

STUDY TITLE: HUMAN IMMUNOGLOBULINS TO PREVENT AND TREAT FLIVIRUS INFECTIONS

Archived on June 20, 2019. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
10:00 AM UTC−10:00
Posted
May 22, 2019
Notice type
Special Notice
NAICS
325413: In-Vitro Diagnostic Substance Manufacturing
Agency
Department of WarDepartment of the Navy

Notice details

Office
NAVAL MEDICAL RESEARCH CENTER
Place of performance
NAVAL MEDICAL RESEARCH CENTER 503 ROBERT GRANT AVENUE, Silver Spring, MD
PSC
A: RESEARCH AND DEVELOPMENT
Last updated
Jan 23, 2026

Identifiers

Solicitation number
N3239819QD030
Notice ID
7da647f0e08a7d4f719d2ab8fc59c245

Description

The United States Department Of Naval Medical Research Center(NMRC) intends to award a sole source contract, SAB Biotherapeutics,Inc., Sioux Falls, SD 57104. This notice is not a request for competitive proposals however If interested Government shall consider all responses. 1. Study Title: Human Immunoglobulins to Prevent and Treat Flivirus Infections - 1 EA. The NAICS code for this action is 325413 This requirement will be procured under the guidelines of FAR Part 12 Commercial Items. NMRC requires that all contractors doing business with the Acquisition Office must be registered with the Systems For Award Management (SAM). No award can be made unless the vendor is registered in Systems For Award Management. For additional information and to register in SAM, please access the following website: http://www.sam.gov/. In order to register with the SAM and to be eligible to receive an award from this Acquisition Office, all offers must have a DUN & Bradstreet Number. A Dun & Bradstreet number may be acquired free of charge by contacting Dun & Bradstreet online at https://www.dnb.com/products/eupdate/requestOptions.html or by phone at (800) 333-0505

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

Showing 1 of 1 items

Document
Source
Agency
Posted Date
File Size
Actions
Special NoticeDEPT OF THE NAVYMay 22, 2019-

Lifecycle

Solicitation:N3239819QD030
  1. Special NoticeCurrentMay 22, 2019

    STUDY TITLE: HUMAN IMMUNOGLOBULINS TO PREVENT AND TREAT FLIVIRUS INFECTIONS

    Notice 7da647f0e08a7d4f719d2ab8fc59c245 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
Please see attached Combined Synopsis/Solicitation. See attached estimated quantities and Questions and Answers.
-Combined Synopsis11/18/2026
-Sole Source / J&AOpen
See Soliciation Amendments 0001, 0002, and 0003. USAISR's Combat Casualty Care Research Team 1 (CRT-1) requires resupply of its Blood Donor Room on a reoccurring basis in order to satisfy research requirements for blood collection. USAISR currently has three Terumo Trima Accel Blood Collection Systems in operation. These units support numerous research protocols. Various collection sets are used to collect a variety of blood products from donors. The Trima instrument is FDA-approved, but only with the use of original manufacturer-supplied consumable products. These consumables are specific to the instrument and there are no generic substitute products available in the marketplace. Please note - This is a 100% set-aside for Service-Disabled Veteran-Owned Small Businesses. See attached complete solicitation for all requirement details and instructions to offerors.
-Solicitation11/20/2026
DESCRIPTION This RFI is solely for information and planning purposes and does not constitute a solicitation or obligation on the part of the Government. Per FAR 15.201(e), responses to this notice are not considered offers, shall not be used as a proposal, and cannot be accepted by the Government to form a binding contract. Neither unsolicited proposals nor any other kinds of offers will be considered in response to this notice. No evaluation letters and/or results will be issued to the respondents; however, the Government does reserve the right to contact any respondent and/or respondent reference to obtain additional information. At this time, no solicitation exists; therefore, please do not request a copy of the solicitation. Any resulting procurement action will be the subject of a separate, future announcement. The information is provided for discussion purposes and any potential strategy for this acquisition may change prior to any solicitation release. The acquisition strategy, evaluation methodology, contract type, and any other acquisition decisions are to be determined. Background. The offeror shall provide to the Veterans Affairs Medical Health Care System at Baltimore VAMC all reagents and supplies for flow cytometry testing in the Hematology section of Pathology and Laboratory Medicine Service. The reagents/supplies will be used for CD4/CD8 count testing and the phenotyping of white blood cells in the leukemia and lymphoma assay using the Becton Dickinson FACSLyric. QC material and calibration material are used for the detection of voltages and spectral overlap to monitor optimal cytometer settings, checks, and track the daily performance. Performance Period: 12/03/2026 to 12/02/2027 Quantities are estimates: Item # Description Qty 643774 Anti-Kappa FITC TB28-2 ASR 4 642924 Anti-Lambda PE 1-55-2 ASR 4 341103 CD19 PE-Cy7 SJ25C1 ASR 4 340922 CD10 APC HI10a ASR 4 641405 CD20 APC-H7 L27 ASR 4 646852 CD38 V450 ASR 3 647450 CD45 V500-C ASR 4 663985 CD5 (L17F12) BV605 ASR 4 340918 FMC7 FITC ASR 4 340997 CD103 PE Ber-ACT8 ASR 2 659116 CD23 APC-R700 (EBVCS-5) ASR 3 655112 CD11c V450 ASR 3 340706 CD57 FITC HNK-1 ASR 3 340948 CD3 PerCP-Cy5.5 SK7 ASR 3 335804 CD2 PE-Cy7 L303.1 ASR 3 562660 Hu CD25 BV605 2A3 100Tst 3 659115 CD7 APC-R700 (M-T701) ASR 3 641409 CD8 APC-H7 SK1 ASR 3 651850 CD4 V450 (SK3) ASR 3 340688 Anti-HLA-DR FITC L243 (G46-6) ASR 3 644386 CD64 PE 10.1 ASR 3 338432 CD13 PE-Cy7 L138 ASR 3 340667 CD34 APC 8G12 ASR 3 659113 CD33 APC-R700 (P67-6) ASR 3 643077 CD14 APC-H7 MphiP9 ASR 3 663803 CD117 (104D2) BV605 ASR 3 657887 CD56 APC-R700 NCAM16.2 ASR 3 563826 Hu Alp Bta TCR APC T10B9.1A-31 100Tst 2 341635 CD30 PE Ber-H83 ASR 2 341097 CD138 PerCP-Cy5.5 MI15 ASR 2 655019 CD27 APC (L128) ASR 2 665134 CD81 (JS-81) BV605 ASR 2 656311 CD22 PerCP-Cy5.5 (S-HCL-1) ASR 3 663994 CD123 (9F5) APC-R700 ASR 2 649455 CD26 PE (L272) ASR 2 655434 TCR gamma/delta-1 PE-Cy7 (11F2) ASR 2 340655 Anti-MPO FITC 5B8 ASR 2 347209 Anti-TdT PE E17-1519 ASR 2 659114 CD34 APC-R700 (8G12) ASR 3 664538 CD22 (S-HCL-1) PE-Cy7 ASR 2 340653 CD79a APC HM47 ASR 2 341641 CD1a PE SK9 ASR 2 663196 CD158a (HP-3E4) PE ASR 2 663990 CD56 (NCAM16.2) BV605 ASR 2 644490 CD 16 V450 3G8 ASR 2 562361 Hu CD94 PerCP-CY5.5 HP-3D9 100Tst 2 562124 Hu CD200 PerCP-Cy5.5 MRC OX-104 50Tst 3 656152 CD36 FITC CLB-IVC7 ASR 2 562371 Hu CD 15 PE W6D3 100Tst 2 340936 CD11b APC D12 ASR 2 347213 CD34 PerCP-Cy5.5 8G12 ASR 2 340715 CD61 FITC RUU-PL7F12 ASR 2 340946 Glycophorin A PE GAR-2(HIR2) ASR 2 644490 CD 16 V450 3G8 ASR 2 662414 CST beads 150T IVD 2 342003 BD FACSFlow Sheath Fluid 20L 20 349202 BD FACS Lysing Solution 10X 100ML IVD 2 559925 7-AAD Staining Solution 2mL 3 563794 Brilliant Stain Buffer 5ml 6 554656 Stain Buffer FBS 500mL 20 552843 Ms Ig Kpa Comp Bead Set 6mL 1 555899 Lysing Buffer 10X Concentrate 100mL 8 340345 BD FACS Clean Solution 5L 1 562776 Ms CD140A PE APA5 50ug 3 340499 Multitest CD3/CD8/CD45/CD4 50 Tests IVD 30 662961 BD FC Beads 7-Color Kit (US-IVD) 1 349705 Multi-Check CD4 Low Ctrl 5X2.5mL US-IVD 6 349702 Multi-Check Control 5X2.5mL US-IVD 6 661624 BD FC Beads V500-C 1 661623 BD FC Beads V450 1 661626 BD FC Beads BV605 1 661621 BD FC Beads APC-H7 1 661625 BD FC Beads APC-R700 1 RESPONSES: Please include descriptive literature demonstrating the product meets or exceeds the brand name product specified above. Please provide any product solution or configuration so long as they are equivalent to the brand name product. Responses can include any additional product that may be beneficial. These items must be clearly identified by brand name and part number. PLEASE PROVIDE THE FOLLOWING ADDITIONAL INFORMATION: Full name and address of company DUNS number/ CAGE Code/ SAM UEI Business Size Manufacturer or Distributor If distributor, provide full name, business size, and address of manufacturer. Country of Origin designation for all products. Technical Literature that clearly shows product(s) are equivalent. Any additional product solution or configuration that would be beneficial to the functionality of the product line identified. Authorized Distributor Letter Certified by OEM with a current date. Although not required, vendors responding to this Sources Sought may also submit a Capabilities Statement.
-Market Research11/12/2026
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98027Q00027. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (including brand-name, if applicable). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm-fixed-price purchase order on a non-competitive basis to Integrated DNA Technologies, Inc. (IDT), 1710 Commercial Park, Coralville, IA 52241, for custom-designed ArcherDX VariantPlex Next-Generation Sequencing (NGS) target-enrichment library preparation kits. Integrated DNA Technologies, Inc. is the sole owner, manufacturer, and distributor of the proprietary ArcherDX VariantPlex Anchored Multiplex PCR (AMP) chemistry, which has been utilized by the NHLBI Hematology Branch since 2019 to perform error-correcting sequencing (ECS) and is required to maintain scientific continuity, prevent technical batch effects across longitudinal patient cohorts, and ensure compatibility with the laboratory¿s established Archer Analysis bioinformatics pipeline. All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026. (iv) The associated NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing) and the small business size standard is 1,250 employees. This requirement is not set aside for small business.
-Combined Synopsis11/05/2026

Additional Details

Solicitation Number

N3239819QD030

Archive Date

Jun 20, 2019

Office Address

SILVER SPRING, MD, 20910-7500